Discover 585 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 585
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
for
NAFLD
Location: Richmond VA
Sponsor: University of Virginia
Sex: All
Age: 18 - 70+
Code: NCT05424003
Phase 2, Recruiting
CIMR Neuromuscular Research Biobank
for
Neuromuscular Diseases, Neuromuscular Disorder,
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 0 - 70+
Code: NCT05434572
Recruiting
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
for
Colorectal Cancer, CRC
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18+
Code: NCT06728072
Phase 2, Recruiting
Research Participation With Transgender and Gender-Diverse Youth
for
Transgender Persons
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 15 - 21
Code: NCT05927350
Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Location: Richmond VA, Hershey PA, Hackensack NJ, Hartford CT,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 30
Code: NCT06541262
Phase 1, Phase 2, Recruiting
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
for
Peripheral Vascular Diseases
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18 - 35
Code: NCT04922762
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
for
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early,
Location: Richmond VA, Durham NC, New York NY, Cleveland OH,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT05832229
Phase 2, Recruiting
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
for
Peripheral Vascular Diseases
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18 - 35
Code: NCT04916340
Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers